Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

166.18
-0.0200-0.01%
Post-market: 166.270.0900+0.05%17:21 EDT
Volume:7.14M
Turnover:1.18B
Market Cap:42.64B
PE:-11.69
High:166.85
Open:166.55
Low:165.27
Close:166.20
52wk High:176.60
52wk Low:141.05
Shares:256.62M
Float Shares:256.62M
Volume Ratio:0.83
T/O Rate:2.78%
Dividend:2.45
Dividend Rate:1.47%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.24
PE(LYR):-11.69

Loading ...

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)

TIPRANKS
·
Yesterday

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Jobs Data

MT Newswires Live
·
Yesterday

Analyst Initiates Buy on GPI, Citing Strong Earnings Quality, Margin Resilience and Long-Term Growth Visibility in Software and Healthcare Solutions

TIPRANKS
·
Yesterday

Health Care Select Sector SPDR: Pivot points

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Yesterday

Correction: Top Midday Decliners

MT Newswires Live
·
Yesterday

Piper Sandler Remains a Buy on Shattuck Labs (STTK)

TIPRANKS
·
Yesterday

Piper Sandler Remains a Buy on Regeneron (REGN)

TIPRANKS
·
Yesterday

EPF Raises Stake in IHH Healthcare to 13.245%

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)

TIPRANKS
·
Yesterday

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

TIPRANKS
·
Yesterday

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

Reuters
·
Yesterday

J&J - Icotyde-Treated Patients Show 70% Clear or Almost Clear Skin at Week 112

THOMSON REUTERS
·
Yesterday

Johnson & Johnson Announces New Icotyde® (Icotrokinra) Data in Difficult-to-Treat Plaque Psoriasis with Proven Durability Through 2-Years, Affirming Its Use as a Powerful First Line Systemic Therapy~

THOMSON REUTERS
·
Yesterday

J&J - 60% Scalp Psoriasis, 89% Genital Psoriasis Patients Achieve Complete Clearance at Week 112

THOMSON REUTERS
·
Yesterday

J&J - Safety Findings Through Week 112 Consistent with Icotyde Profile, no New Safety Signals

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

TIPRANKS
·
Yesterday

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

GlobeNewswire
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday